ALLISON RUBLAITUS: Open Payments
NPI 1609412436 · SYLVANIA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,737 in 107 payments from 12 companies in 2025. Trend: 2023 $606 · 2024 $1,769 · 2025 $1,737
Food & beverage: $1,737
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $411 |
| Aimmune Therapeutics, Inc. | 15 | $257 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 17 | $243 |
| GENZYME CORPORATION | 14 | $198 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $192 |
| Madrigal Pharmaceuticals | 6 | $119 |
| Ardelyx, Inc. | 4 | $89 |
| Janssen Biotech, Inc. | 3 | $64 |
| QOL Medical, LLC | 4 | $62 |
| Ipsen Biopharmaceuticals, Inc | 2 | $46 |
Products named: XIFAXAN, ZENPEP, DUPIXENT, CREON, ENTYVIO, REZDIFFRA, RINVOQ, IBSRELA.
Industry payments across OH — which companies pay providers there.
